| 1 | [SID3717305] | Active | EC50 | 0.582 | Luminescence Cell-Based Dose Response to Identify Activators of Luciferase Translation or Activity in H4-C Neuroglioblastoma Cells [AID2456, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | EC50 | 0.582 [uM] | | BioAssay | Luminescence Cell-Based Dose Response to Identify Activators of Luciferase Translation or Activity in H4-C Neuroglioblastoma Cells | | AID | 2456 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID3717305] | Active | EC50 | 0.66 | Luminescence Cell-Based Dose Response to Identify Activators of 5'UTR Stem-Loop Driven Prion Protein mRNA Translation in H4-C Neuroglioblastoma Cells [AID2457, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | EC50 | 0.66 [uM] | | BioAssay | Luminescence Cell-Based Dose Response to Identify Activators of 5'UTR Stem-Loop Driven Prion Protein mRNA Translation in H4-C Neuroglioblastoma Cells | | AID | 2457 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID3717305] | Active | EC50 | 1.079 | Luminescence Cell-Based Dose Confimation to Identify Activators of 5'UTR Stem-Loop Driven Alpha-Synuclein mRNA Translation in H4 Neuroglioblastoma Cells [AID2450, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | EC50 | 1.079 [uM] | | BioAssay | Luminescence Cell-Based Dose Confimation to Identify Activators of 5'UTR Stem-Loop Driven Alpha-Synuclein mRNA Translation in H4 Neuroglioblastoma Cells | | AID | 2450 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID3717305] | Active | Potency | 3.1623 | qHTS Assay for Rab9 Promoter Activators [AID485297, Type: confirmatory] | RAB9A gene product [Homo sapiens] [gi:4759012] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS Assay for Rab9 Promoter Activators | | AID | 485297 | | BioAssay type | confirmatory | | Target | RAB9A gene product [Homo sapiens] [gi:4759012] | | PubMed | | | Data Table |  |
|
| 5 | [SID3717305] | Active | Potency | 3.1623 | qHTS Assay for NPC1 Promoter Activators [AID485313, Type: confirmatory] | NPC1 gene product [Homo sapiens] [gi:255652944] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | Potency | 3.1623 [uM] | | BioAssay | qHTS Assay for NPC1 Promoter Activators | | AID | 485313 | | BioAssay type | confirmatory | | Target | NPC1 gene product [Homo sapiens] [gi:255652944] | | PubMed | | | Data Table |  |
|
| 6 | [SID3717305] | Active | Potency | 6.7456 | qHTS of Nrf2 Activators: Hit Validation in Secondary FLuc Assay [AID651597, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | Potency | 6.7456 [uM] | | BioAssay | qHTS of Nrf2 Activators: Hit Validation in Secondary FLuc Assay | | AID | 651597 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 7 | [SID3717305] | Active | Potency | 6.7456 | qHTS of Nrf2 Activators: Hit Validation in Secondary FLuc Assay [AID651597, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | Potency | 6.7456 [uM] | | BioAssay | qHTS of Nrf2 Activators: Hit Validation in Secondary FLuc Assay | | AID | 651597 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 8 | [SID3717305] | Active | Potency | 6.7456 | qHTS of Nrf2 Activators: Hit Validation in Secondary FLuc Assay [AID651597, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | Potency | 6.7456 [uM] | | BioAssay | qHTS of Nrf2 Activators: Hit Validation in Secondary FLuc Assay | | AID | 651597 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 9 | [SID3717305] | Active | Potency | 6.7456 | qHTS of Nrf2 Activators: Hit Validation in Secondary FLuc Assay [AID651597, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | Potency | 6.7456 [uM] | | BioAssay | qHTS of Nrf2 Activators: Hit Validation in Secondary FLuc Assay | | AID | 651597 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 10 | [SID3717305] | Active | Potency | 7.0795 | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 11 | [SID3717305] | Active | Potency | 7.0795 | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 12 | [SID3717305] | Active | Potency | 7.0795 | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 13 | [SID3717305] | Active | Potency | 7.0795 | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 14 | [SID3717305] | Active | Potency | 7.3078 | qHTS of Nrf2 Activators: Hit Validation in Primary Assay [AID651593, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | Potency | 7.3078 [uM] | | BioAssay | qHTS of Nrf2 Activators: Hit Validation in Primary Assay | | AID | 651593 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 15 | [SID3717305] | Active | Potency | 7.3078 | qHTS of Nrf2 Activators: Hit Validation in Primary Assay [AID651593, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | Potency | 7.3078 [uM] | | BioAssay | qHTS of Nrf2 Activators: Hit Validation in Primary Assay | | AID | 651593 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 16 | [SID3717305] | Active | Potency | 7.3078 | qHTS of Nrf2 Activators: Hit Validation in Primary Assay [AID651593, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | Potency | 7.3078 [uM] | | BioAssay | qHTS of Nrf2 Activators: Hit Validation in Primary Assay | | AID | 651593 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 17 | [SID3717305] | Active | Potency | 7.3078 | qHTS of Nrf2 Activators: Hit Validation in Primary Assay [AID651593, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | Potency | 7.3078 [uM] | | BioAssay | qHTS of Nrf2 Activators: Hit Validation in Primary Assay | | AID | 651593 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 18 | [SID3717305] | Active | EC50 | 11.088 | Luminescence Cell-Based Dose Response HTS to Identify Activators of 5'UTR Stem-Loop Driven Prion Protein mRNA Translation in H4 Neuroglioblastoma Cells [AID1999, Type: confirmatory] | |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | EC50 | 11.088 [uM] | | BioAssay | Luminescence Cell-Based Dose Response HTS to Identify Activators of 5'UTR Stem-Loop Driven Prion Protein mRNA Translation in H4 Neuroglioblastoma Cells | | AID | 1999 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 19 | [SID3717305] | Active | EC50 | 16.641 | Luminescence Cell-Based Dose Response HTS to Identify Activators of Luciferase Translation or Activity in H4 Neuroglioblastoma Cells [AID2002, Type: confirmatory] | |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | EC50 | 16.641 [uM] | | BioAssay | Luminescence Cell-Based Dose Response HTS to Identify Activators of Luciferase Translation or Activity in H4 Neuroglioblastoma Cells | | AID | 2002 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 20 | [SID3717305] | Active | Potency | 16.9441 | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) [AID588342, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | Potency | 16.9441 [uM] | | BioAssay | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) | | AID | 588342 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|
| 21 | [SID3717305] | Active | Potency | 44.6684 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 22 | [SID3717305] | Active | | | Primary Cell-Based Assay to Identify Agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4) [AID1509, Type: screening] | Sphingosine-1-phosphate receptor 4 [Homo sapiens] [gi:15929025] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | BioAssay | Primary Cell-Based Assay to Identify Agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4) | | AID | 1509 | | BioAssay type | screening | | Target | Sphingosine-1-phosphate receptor 4 [Homo sapiens] [gi:15929025] | | PubMed | | | Data Table |  |
|
| 23 | [SID3717305] | Active | | | Primary Cell-Based Assay to Identify Agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4) [AID1509, Type: screening] | Sphingosine-1-phosphate receptor 4 [Homo sapiens] [gi:15929025] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | BioAssay | Primary Cell-Based Assay to Identify Agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4) | | AID | 1509 | | BioAssay type | screening | | Target | Sphingosine-1-phosphate receptor 4 [Homo sapiens] [gi:15929025] | | PubMed | | | Data Table |  |
|
| 24 | [SID3717305] | Active | | | HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS [AID485317, Type: screening] | FAD-linked sulfhydryl oxidase ALR [Homo sapiens] [gi:54112432] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | BioAssay | HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS | | AID | 485317 | | BioAssay type | screening | | Target | FAD-linked sulfhydryl oxidase ALR [Homo sapiens] [gi:54112432] | | PubMed | | | Data Table |  |
|
| 25 | [SID3717305] | Active | | | Primary Cell-based High Throughput Screening assay for activators of the nuclear receptor Steroidogenic Factor 1 (SF-1) [AID522, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | BioAssay | Primary Cell-based High Throughput Screening assay for activators of the nuclear receptor Steroidogenic Factor 1 (SF-1) | | AID | 522 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 26 | [SID3717305] | Active | | | Primary Cell-based High Throughput Screening assay for activators of the nuclear receptor Steroidogenic Factor 1 (SF-1) [AID522, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | BioAssay | Primary Cell-based High Throughput Screening assay for activators of the nuclear receptor Steroidogenic Factor 1 (SF-1) | | AID | 522 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 27 | [SID3717305] | Active | | | Primary Cell-based High Throughput Screening assay for activators of the nuclear receptor Steroidogenic Factor 1 (SF-1) [AID522, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | BioAssay | Primary Cell-based High Throughput Screening assay for activators of the nuclear receptor Steroidogenic Factor 1 (SF-1) | | AID | 522 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 28 | [SID3717305] | Active | | | High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen [AID1239, Type: screening] | NFKB1 gene product [Homo sapiens] [gi:34577122] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | BioAssay | High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen | | AID | 1239 | | BioAssay type | screening | | Target | NFKB1 gene product [Homo sapiens] [gi:34577122] | | PubMed | | | Data Table |  |
|
| 29 | [SID3717305] | Active | | | High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen [AID1239, Type: screening] | NFKB1 gene product [Homo sapiens] [gi:34577122] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | BioAssay | High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen | | AID | 1239 | | BioAssay type | screening | | Target | NFKB1 gene product [Homo sapiens] [gi:34577122] | | PubMed | | | Data Table |  |
|
| 30 | [SID3717305] | Active | | | High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen [AID1239, Type: screening] | NFKB1 gene product [Homo sapiens] [gi:34577122] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | BioAssay | High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen | | AID | 1239 | | BioAssay type | screening | | Target | NFKB1 gene product [Homo sapiens] [gi:34577122] | | PubMed | | | Data Table |  |
|
| 31 | [SID3717305] | Active | | | High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen [AID1239, Type: screening] | NFKB1 gene product [Homo sapiens] [gi:34577122] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | BioAssay | High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen | | AID | 1239 | | BioAssay type | screening | | Target | NFKB1 gene product [Homo sapiens] [gi:34577122] | | PubMed | | | Data Table |  |
|
| 32 | [SID3717305] | Active | | | Primary Cell-based High Throughput Screening assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA) [AID560, Type: screening] | Nuclear receptor ROR-alpha [gi:548814] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | BioAssay | Primary Cell-based High Throughput Screening assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA) | | AID | 560 | | BioAssay type | screening | | Target | Nuclear receptor ROR-alpha [gi:548814] | | PubMed | | | Data Table |  |
|
| 33 | [SID3717305] | Active | | | Primary Cell-based High Throughput Screening assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA) [AID560, Type: screening] | Nuclear receptor ROR-alpha [gi:548814] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | BioAssay | Primary Cell-based High Throughput Screening assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA) | | AID | 560 | | BioAssay type | screening | | Target | Nuclear receptor ROR-alpha [gi:548814] | | PubMed | | | Data Table |  |
|
| 34 | [SID3717305] | Active | | | Primary Cell-based High Throughput Screening assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA) [AID560, Type: screening] | Nuclear receptor ROR-alpha [gi:548814] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | BioAssay | Primary Cell-based High Throughput Screening assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA) | | AID | 560 | | BioAssay type | screening | | Target | Nuclear receptor ROR-alpha [gi:548814] | | PubMed | | | Data Table |  |
|
| 35 | [SID3717305] | Active | | | Primary Cell-based High Throughput Screening assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA) [AID560, Type: screening] | Nuclear receptor ROR-alpha [gi:548814] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | BioAssay | Primary Cell-based High Throughput Screening assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA) | | AID | 560 | | BioAssay type | screening | | Target | Nuclear receptor ROR-alpha [gi:548814] | | PubMed | | | Data Table |  |
|
| 36 | [SID3717305] | Active | | | Primary cell-based high throughput screening assay to measure STAT1 activation [AID932, Type: screening] | signal transducer and activator of transcription 1-alpha/beta isoform alpha [Homo sapiens] [gi:6274552] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | BioAssay | Primary cell-based high throughput screening assay to measure STAT1 activation | | AID | 932 | | BioAssay type | screening | | Target | signal transducer and activator of transcription 1-alpha/beta isoform alpha [Homo sapiens] [gi:6274552] | | PubMed | | | Data Table |  |
|
| 37 | [SID3717305] | Active | | | Primary cell-based high throughput screening assay to measure STAT1 activation [AID932, Type: screening] | signal transducer and activator of transcription 1-alpha/beta isoform alpha [Homo sapiens] [gi:6274552] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | BioAssay | Primary cell-based high throughput screening assay to measure STAT1 activation | | AID | 932 | | BioAssay type | screening | | Target | signal transducer and activator of transcription 1-alpha/beta isoform alpha [Homo sapiens] [gi:6274552] | | PubMed | | | Data Table |  |
|
| 38 | [SID3717305] | Active | | | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin [AID2314, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | BioAssay | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin | | AID | 2314 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 39 | [SID3717305] | Active | | | A qHTS for Small Molecule Inhibitors of Shiga Toxin [AID2315, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | BioAssay | A qHTS for Small Molecule Inhibitors of Shiga Toxin | | AID | 2315 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 40 | [SID3717305] | Active | | | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators [AID1814, Type: screening] | |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | BioAssay | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators | | AID | 1814 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 41 | [SID3717305] | Active | | | CYP2C19 Assay [AID778, Type: screening] | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | BioAssay | CYP2C19 Assay | | AID | 778 | | BioAssay type | screening | | Target | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] | | PubMed | | | Data Table |  |
|
| 42 | [SID3717305] | Active | | | CYP2C19 Assay [AID778, Type: screening] | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Active | | BioAssay | CYP2C19 Assay | | AID | 778 | | BioAssay type | screening | | Target | cytochrome P450, family 2, subfamily C, polypeptide 19 [Homo sapiens] [gi:4503219] | | PubMed | | | Data Table |  |
|
| 43 | [SID3717305] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 44 | [SID3717305] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 45 | [SID3717305] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 46 | [SID3717305] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 47 | [SID3717305] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 48 | [SID3717305] | Inactive | Potency | 4.14 | qHTS Assay for Modulators of miRNAs and/orActivators of miR-21 [AID2288, Type: confirmatory] | |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Inactive | | Potency | 4.14 [uM] | | BioAssay | qHTS Assay for Modulators of miRNAs and/orActivators of miR-21 | | AID | 2288 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 49 | [SID3717305] | Inactive | Potency | 7.3753 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Inactive | | Potency | 7.3753 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 50 | [SID3717305] | Inactive | Potency | 89.1251 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 3717305 | | CID | 6904877 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|